Integrated Microfluidic Devices Fabricated in Poly (Methyl Methacrylate) (PMMA) for On-site Therapeutic Drug Monitoring of Aminoglycosides in Whole Blood

scientific article published on 30 January 2019

Integrated Microfluidic Devices Fabricated in Poly (Methyl Methacrylate) (PMMA) for On-site Therapeutic Drug Monitoring of Aminoglycosides in Whole Blood is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.3390/BIOS9010019
P932PMC publication ID6468438
P698PubMed publication ID30704056

P50authorMichael C BreadmoreQ63150215
Zaidon T Al-AqbiQ91293431
P2093author name stringFeng Li
Yiing C Yap
P2860cites workPersonalized medicine and human genetic diversityQ26824838
Therapeutic drug monitoring of the β-lactam antibiotics: what is the evidence and which patients should we be using it for?Q28080607
The therapeutic monitoring of antimicrobial agentsQ28356180
Electrokinetic protein preconcentration using a simple glass/poly(dimethylsiloxane) microfluidic chipQ33250192
Maskless photolithography using UV LEDsQ33354422
Current methodologies for the analysis of aminoglycosidesQ34096989
Application of pharmacokinetic modelling to the routine therapeutic drug monitoring of anticancer drugsQ35060593
Therapeutic drug monitoring of the newer antiepileptic drugsQ35135903
Cost-effectiveness of therapeutic drug monitoring: a systematic review.Q36017722
Practical guidelines for therapeutic drug monitoring of anticancer tyrosine kinase inhibitors: focus on the pharmacokinetic targetsQ38190857
Therapeutic drug monitoring principles in the neonate. National Academy of CLinical Biochemistry.Q41302992
Poly(dimethylsiloxane)-based protein preconcentration using a nanogap generated by junction gap breakdownQ41504252
Analysis of small molecules for clinical diagnosis by capillary electrophoresisQ41645293
Therapeutic Drug Monitoring of the new targeted anticancer agents imatinib, nilotinib, dasatinib, sunitinib, sorafenib and lapatinib by LC tandem mass spectrometry.Q45977906
Simple and sensitive method for quantification of low tobramycin concentrations in human plasma using HPLC-MS/MS.Q46820854
Electrokinetic Size and Mobility Traps for On-site Therapeutic Drug MonitoringQ47389442
Microchip capillary electrophoresis for point-of-care analysis of lithium.Q51100169
Nanoporous Membranes for Microfluidic Concentration Prior to Electrophoretic Separation of Proteins in Urine.Q51258805
Tuneable nanochannel formation for sample-in/answer-out devicesQ57125874
High intensity light emitting diode array as an alternative exposure source for the fabrication of electrophoretic microfluidic devicesQ60430436
Flow-dependent separation selectivity for organic molecules on metal–organic frameworks containing adsorbentsQ61897456
Evaluation of the Abbott IMx fluorescence polarization immunoassay and the bio-rad enzyme immunoassay for homocysteine: comparison with high-performance liquid chromatographyQ73588775
Antiepileptic drugs--best practice guidelines for therapeutic drug monitoring: a position paper by the subcommission on therapeutic drug monitoring, ILAE Commission on Therapeutic StrategiesQ81041318
A novel electrochemical immunosensor for the quantitative detection of 5-hydroxymethylcytosine in genomic DNA of breast cancer tissueQ85936953
P275copyright licenseCreative Commons Attribution 4.0 InternationalQ20007257
P6216copyright statuscopyrightedQ50423863
P433issue1
P407language of work or nameEnglishQ1860
P921main subjectmicrofluidicsQ138845
whole bloodQ7997549
microfluidic deviceQ105460056
P304page(s)19
P577publication date2019-01-30
P1433published inBiosensorsQ27724883
P1476titleIntegrated Microfluidic Devices Fabricated in Poly (Methyl Methacrylate) (PMMA) for On-site Therapeutic Drug Monitoring of Aminoglycosides in Whole Blood
P478volume9